Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.52M Sell
52,505
-1,107
-2% -$131K 0.03% 372
2025
Q4
$6.36M Sell
53,612
-785
-1% -$93.7K 0.03% 343
2025
Q3
$6.72M Buy
+54,397
New +$6.51M 0.04% 325
2024
Q4
Sell
-14,493
Closed -$1.35M 676
2024
Q3
$1.35M Sell
14,493
-24,421
-63% -$2.43M 0.01% 549
2024
Q2
$4.16M Sell
38,914
-11,564
-23% -$1.38M 0.03% 367
2024
Q1
$6.08M Buy
50,478
+7,872
+18% +$881K 0.04% 307
2023
Q4
$4.69M Hold
42,606
0.03% 339
2023
Q3
$4.11M Buy
42,606
+10,808
+34% +$1.04M 0.03% 328
2023
Q2
$2.7M Sell
31,798
-15,941
-33% -$1.38M 0.02% 444
2023
Q1
$4.1M Buy
47,739
+35,981
+306% +$3.18M 0.03% 412
2022
Q4
$900K Sell
11,758
-5,420
-32% -$433K 0.01% 717
2022
Q3
$1.15M Hold
17,178
0.01% 683
2022
Q2
$1.23M Hold
17,178
0.01% 598
2022
Q1
$1.31M Buy
17,178
+4,958
+41% +$456K 0.01% 613
2021
Q4
$1.26M Buy
+12,220
New +$1.2M 0.01% 620
2021
Q2
Sell
-45,469
Closed -$4.02M 890
2021
Q1
$4.02M Hold
45,469
0.03% 411
2020
Q4
$4.19M Sell
45,469
-6,391
-12% -$552K 0.03% 422
2020
Q3
$3.78M Buy
51,860
+46,500
+868% +$3.3M 0.04% 393
2020
Q2
$346K Sell
5,360
-3,744
-41% -$225K ﹤0.01% 728
2020
Q1
$751K Hold
9,104
0.01% 680
2019
Q4
$768K Sell
9,104
-21,912
-71% -$1.79M 0.01% 697
2019
Q3
$2.45M Sell
31,016
-15,372
-33% -$1.09M 0.03% 452
2019
Q2
$3.26M Buy
46,388
+967
+2% +$70.7K 0.04% 422
2019
Q1
$3.34M Buy
45,421
+20,783
+84% +$1.61M 0.04% 399
2018
Q4
$1.73M Buy
24,638
+816
+3% +$66.2K 0.03% 488
2018
Q3
$2.06M Buy
23,822
+13,795
+138% +$1.32M 0.03% 498
2018
Q2
$1.03M Buy
10,027
+47
+0.5% +$5.02K 0.02% 603
2018
Q1
$1.05M Buy
9,980
+1,206
+14% +$124K 0.02% 590
2017
Q4
$803K Hold
8,774
0.01% 621
2017
Q3
$781K Buy
8,774
+1,104
+14% +$89.6K 0.01% 606
2017
Q2
$607K Hold
7,670
0.01% 640
2017
Q1
$565K Buy
7,670
+1,921
+33% +$149K 0.01% 636
2016
Q4
$469K Sell
5,749
-31
-0.5% -$2.3K 0.01% 617
2016
Q3
$445K Buy
5,780
+1,430
+33% +$110K 0.01% 610
2016
Q2
$337K Buy
+4,350
New +$373K 0.01% 616

Other funds holding ALV

Candriam SCA's ALV Position: Q1 2026 in Review

Candriam SCA reduced its Autoliv (ALV) stake by 2.1% in Q1 2026, selling an estimated $131K and leaving 52,505 shares worth $5.52M. The position accounts for 0.03% of the portfolio, ranked #372.

Candriam SCA first reported a position in ALV in Q2 2016 and has held it in 35 quarters since. The position peaked at $6.72M in Q3 2025. 409 funds tracked by Wall St. Rank hold ALV as of Q1 2026.

  • Candriam SCA held 52,505 shares of Autoliv worth $5.52M as of Q1 2026.
  • Candriam SCA sold 1,107 Autoliv shares in Q1 2026, an estimated $131K.
  • Autoliv made up 0.03% of Candriam SCA's portfolio in Q1 2026, its #372 holding.
  • Candriam SCA first reported a position in Autoliv in Q2 2016 and has held it in 35 quarters since.
  • Candriam SCA's Autoliv position peaked at $6.72M in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Autoliv as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.